Effect of Ranolazine on Valvular Disease in Patients With Pacemakers
Status:
Unknown status
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out whether mitral regurgitation (or a leaky heart
valve) caused by ischemic heart disease (decreased blood flow to heart muscle) will improve
after administration of ranolazine.